HIP
ALT icon

HUB Investment Partners’s Altimmune ALT Stock Holding History

HUB Investment Partners’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.2K Buy
30,319
+101
+0.3% +$302 ﹤0.01% 1288
2026
Q1 		$93.1K Buy
30,218
+16,000
+113% +$67.9K ﹤0.01% 1069
2025
Q4 		$51.3K Buy
+14,218
New +$62K ﹤0.01% 933

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HUB Investment Partners's ALT Position: Q2 2026 in Review

HUB Investment Partners increased its Altimmune (ALT) stake by 0.33% in Q2 2026, buying an estimated $302 and bringing the position to 30,319 shares worth $92.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

HUB Investment Partners first reported a position in ALT in Q4 2025 and has held it in 3 quarters since. The position peaked at $93.1K in Q1 2026. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • HUB Investment Partners held 30,319 shares of Altimmune worth $92.2K as of Q2 2026.
  • HUB Investment Partners bought 101 Altimmune shares in Q2 2026, an estimated $302.
  • Altimmune made up ﹤0.01% of HUB Investment Partners's portfolio in Q2 2026, its #1288 holding.
  • HUB Investment Partners first reported a position in Altimmune in Q4 2025 and has held it in 3 quarters since.
  • HUB Investment Partners's Altimmune position peaked at $93.1K in Q1 2026.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.